🚀 VC round data is live in beta, check it out!
- Public Comps
- ADDvise Group
ADDvise Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for ADDvise Group and similar public comparables like Laxmi Dental, Sopharma Trading, SDI, Kewaunee Scientific and more.
ADDvise Group Overview
About ADDvise Group
ADDvise Group AB e is an international life science company. Operating a decentralized ownership model, in which company develop and acquire high quality companies within the business areas Lab and Healthcare.
Founded
1989
HQ

Employees
641
Website
Sectors
Financials (LTM)
EV
$229M
ADDvise Group Financials
ADDvise Group reported last 12-month revenue of $180M and EBITDA of $38M.
In the same LTM period, ADDvise Group generated $38M in EBITDA and $7M in net income.
Revenue (LTM)
ADDvise Group P&L
In the most recent fiscal year, ADDvise Group reported revenue of — and net income of —.
ADDvise Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $180M | XXX | — | XXX | XXX | XXX |
| EBITDA | $38M | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | — | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | — | XXX | XXX | XXX |
| Net Profit | $7M | XXX | — | XXX | XXX | XXX |
| Net Margin | 4% | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
ADDvise Group Stock Performance
ADDvise Group has current market cap of $115M, and enterprise value of $229M.
ADDvise Group's stock price is $0.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $229M | $115M | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialADDvise Group Valuation Multiples
ADDvise Group trades at 1.3x EV/Revenue multiple, and 6.1x EV/EBITDA.
ADDvise Group Financial Valuation Multiples
As of April 11, 2026, ADDvise Group has market cap of $115M and EV of $229M.
Equity research analysts estimate ADDvise Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ADDvise Group has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $115M | XXX | $115M | XXX | XXX | XXX |
| EV (current) | $229M | XXX | $229M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | 6.1x | XXX | — | XXX | XXX | XXX |
| EV/EBIT | 8.7x | XXX | — | XXX | XXX | XXX |
| P/E | 16.9x | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ADDvise Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


ADDvise Group Margins & Growth Rates
ADDvise Group's revenue in the last 12 month grew by 1%.
ADDvise Group's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ADDvise Group's rule of X is 18% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
ADDvise Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | (2%) | XXX | — | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
ADDvise Group Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Laxmi Dental | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma Trading | XXX | XXX | XXX | XXX | XXX | XXX |
| SDI | XXX | XXX | XXX | XXX | XXX | XXX |
| Kewaunee Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Farminveste | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ADDvise Group M&A Activity
ADDvise Group acquired XXX companies to date.
Last acquisition by ADDvise Group was on XXXXXXXX, XXXXX. ADDvise Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by ADDvise Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialADDvise Group Investment Activity
ADDvise Group invested in XXX companies to date.
ADDvise Group made its latest investment on XXXXXXXX, XXXXX. ADDvise Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by ADDvise Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ADDvise Group
| When was ADDvise Group founded? | ADDvise Group was founded in 1989. |
| Where is ADDvise Group headquartered? | ADDvise Group is headquartered in Sweden. |
| How many employees does ADDvise Group have? | As of today, ADDvise Group has over 641 employees. |
| Is ADDvise Group publicly listed? | Yes, ADDvise Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of ADDvise Group? | ADDvise Group trades under ADDV B ticker. |
| When did ADDvise Group go public? | ADDvise Group went public in 2015. |
| Who are competitors of ADDvise Group? | ADDvise Group main competitors are Laxmi Dental, Sopharma Trading, SDI, Kewaunee Scientific. |
| What is the current market cap of ADDvise Group? | ADDvise Group's current market cap is $115M. |
| What is the current revenue of ADDvise Group? | ADDvise Group's last 12 months revenue is $180M. |
| What is the current revenue growth of ADDvise Group? | ADDvise Group revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of ADDvise Group? | Current revenue multiple of ADDvise Group is 1.3x. |
| Is ADDvise Group profitable? | Yes, ADDvise Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of ADDvise Group? | ADDvise Group's last 12 months EBITDA is $38M. |
| What is ADDvise Group's EBITDA margin? | ADDvise Group's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of ADDvise Group? | Current EBITDA multiple of ADDvise Group is 6.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.